Lab
Salud Integral En LA Montana, INC
Salud Integral En LA Montana, INC was paid $2.13M by Medicaid between Jan 2018 and Oct 2024, across 81 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 9.5% of everything it billed.
33Billing provider infoSALUD INTEGRAL EN LA MONTANA, INC
COROZAL, PR 00783
COROZAL, PR 00783
33aNPI1124377452assigned 08/31/2012
33bProvider typeClinical Medical Laboratory
28Total paid$2.13M
24GClaims197,950
24DCodes billed81
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#45 of 777
Median peer was paid$278K
This provider vs. median7.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,965 | $21K | |
| 2019 | 25,155 | $266K | |
| 2020 | 19,919 | $268K | |
| 2021 | 28,393 | $379K | |
| 2022 | 25,448 | $262K | |
| 2023 | 36,958 | $430K | |
| 2024incomplete | 36,112 | $506K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 9.5% | 15,060 | 14,038 | $202K |
| 80061 | Lipid panel | 8.8% | 16,846 | 15,730 | $187K |
| 80074 | 8.7% | 4,508 | 4,212 | $186K | |
| 80053 | Comprehensive metabolic panel | 7.9% | 19,687 | 18,296 | $169K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.9% | 26,372 | 24,058 | $168K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.8% | 4,204 | 3,891 | $145K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.6% | 5,157 | 4,783 | $119K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.9% | 3,117 | 2,802 | $105K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 2,619 | 2,360 | $102K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.4% | 11,759 | 11,029 | $94K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 1,676 | 1,479 | $75K |
| 86703 | 3.5% | 7,495 | 6,985 | $75K |
69 more codes
| 84439 | 3.3% | 9,407 | $70K | |
| 81000 | 2.5% | 20,236 | $54K | |
| 82274 | 2.5% | 4,426 | $53K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 5,481 | $36K |
| 84153 | 1.3% | 2,026 | $29K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 2,767 | $27K |
| 86738 | 1.1% | 1,792 | $24K | |
| 83970 | 1.0% | 553 | $22K | |
| 86592 | <1% | 5,342 | $19K | |
| 82607 | <1% | 1,269 | $18K | |
| 82044 | <1% | 4,031 | $13K | |
| 86038 | <1% | 1,305 | $13K | |
| 82570 | <1% | 2,385 | $11K | |
| 86803 | <1% | 611 | $8K | |
| 85651 | <1% | 2,570 | $7K | |
| 83655 | <1% | 623 | $6K | |
| 85730 | <1% | 1,129 | $6K | |
| 82043 | <1% | 962 | $6K | |
| 87177 | <1% | 1,155 | $5K | |
| 86140 | <1% | 1,149 | $5K | |
| 86800 | <1% | 309 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 122 | $4K |
| 86376 | <1% | 326 | $4K | |
| 85610 | <1% | 1,188 | $4K | |
| 80069 | <1% | 485 | $4K | |
| 82785 | <1% | 178 | $3K | |
| 82728 | <1% | 282 | $3K | |
| 86160 | <1% | 276 | $3K | |
| 80050 | General health panel | <1% | 381 | $3K |
| 86225 | <1% | 234 | $3K | |
| 86256 | <1% | 276 | $3K | |
| 82950 | <1% | 809 | $3K | |
| 84156 | <1% | 1,023 | $3K | |
| 86235 | <1% | 136 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 288 | $2K |
| 84550 | <1% | 528 | $2K | |
| 83540 | <1% | 316 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 177 | $2K |
| 83001 | <1% | 99 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 71 | $2K |
| 86431 | <1% | 311 | $2K | |
| 82951 | <1% | 155 | $2K | |
| 84154 | <1% | 94 | $2K | |
| 82746 | <1% | 99 | $1K | |
| 86694 | <1% | 73 | $1K | |
| 82947 | <1% | 339 | $918.12 | |
| 82952 | <1% | 371 | $782.66 | |
| 83550 | <1% | 99 | $699.31 | |
| 84703 | <1% | 91 | $635.87 | |
| 87340 | <1% | 55 | $595.74 | |
| 84436 | <1% | 367 | $454.51 | |
| 84100 | <1% | 120 | $449.12 | |
| 86328 | <1% | 33 | $418.00 | |
| 82105 | <1% | 25 | $329.04 | |
| 80076 | <1% | 81 | $223.40 | |
| 84481 | <1% | 12 | $221.52 | |
| 85044 | <1% | 44 | $198.83 | |
| 86430 | <1% | 117 | $140.96 | |
| 83735 | <1% | 16 | $113.20 | |
| 82150 | <1% | 15 | $98.84 | |
| 83690 | <1% | 14 | $97.50 | |
| 83615 | <1% | 16 | $90.65 | |
| 86886 | <1% | 12 | $66.29 | |
| 82977 | <1% | 14 | $58.54 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 104 | $41.40 |
| 86901 | <1% | 13 | $40.91 | |
| 86900 | <1% | 13 | $40.91 | |
| 82565 | <1% | 12 | $35.90 | |
| 84520 | <1% | 12 | $27.68 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, SANDRA (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Salud Integral En LA Montana, INC | Naranjito, PR | $3.65M |
| Sandra Patricia Garcia DPM PC | Bronx, NY | $204K |
| Sandra Patricia Garcia DPM PC | Flushing, NY | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.